| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.5M | +116.3% |
| Cost of Revenue | $3.7M | +88.4% |
| R&D Expense | $490K | +195.1% |
| SG&A Expense | $9.1M | +21.3% |
| Operating Income | -$8.1M | -20.1% |
| Interest Expense | $1.1M | +14.1% |
| Pre-tax Income | -$9.1M | -13.9% |
| Income Tax | -$23K | -182.5% |
| Net Income | -$9.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $175K | +24.4% |
| Inventory | $220K | -16.9% |
| Current Assets | $1.3M | +4.6% |
| Total Assets | $46.4M | +122.4% |
| Current Liabilities | $17.9M | +118.1% |
| Total Liabilities | $26.2M | +31.3% |
| Stockholders' Equity | $12.7M | +1327.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | +37.4% |
| Capital Expenditures | $184K | -58.7% |
| Investing Cash Flow | $364K | +114.6% |
| Financing Cash Flow | $3.1M | -57.8% |
| Free Cash Flow | -$3.2M | +39.3% |
| -13.2% |
| EPS (Basic) | -$30.19 | -488.5% |
| EPS (Diluted) | -$30.19 | -488.5% |